A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Ann Oncol
; 28(11): 2820-2826, 2017 Nov 01.
Article
in En
| MEDLINE
| ID: mdl-28950305
Full text:
1
Database:
MEDLINE
Main subject:
Carcinoma, Squamous Cell
/
Antineoplastic Combined Chemotherapy Protocols
/
Head and Neck Neoplasms
/
Neoplasm Recurrence, Local
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2017
Type:
Article